BILLEV PHARMA ApS: Financial statements 2025
CVR: 81814813
Source: annual report 2025, Danish Business Authority
01/05/2024 – 30/04/2025
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 31,189,057 and a net result of DKK 6,143,854 compared with DKK 3,378,539 the year before. That is an increase of 25.9% compared with the year before. Equity in the 2025 report amounted to DKK 6,463,854. The solvency ratio was 52.6%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 31,189,057
- Profit/Loss
- DKK 6,143,854
- Equity
- DKK 6,463,854
- Total Assets
- DKK 12,279,752
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 31.2 mio. | 6.1 mio. | 6.5 mio. | 21 |
| 2024 | - | 24.8 mio. | 3.4 mio. | 3.7 mio. | 19 |
| 2023 | - | 29.1 mio. | 4.9 mio. | 5.3 mio. | 21 |
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
Official annual report
How creditworthy is BILLEV PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.